Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to use the Dutch company’s three-pronged ADC tech.
It’s been a busy year for Synaffix: It was acquired by Lonza in June and the…
Click here to view original post
